Form 4: Lemaitre Vascular Exec's Routine Stock Transactions

A Lemaitre Vascular Senior VP reported routine acquisitions of common stock and dividend equivalent rights, alongside a tax-related sale of shares.

Summary

• Trent G. Kamke, Senior V. P., Operations at Lemaitre Vascular Inc., reported several transactions involving the company's common stock and dividend equivalent rights (DERs).
• On December 6, 2025, Kamke acquired 2 shares of common stock at a price of $0, representing shares released from dividend equivalent rights.
• Also on December 6, 2025, 69 shares of common stock were disposed of at $84.53 per share to satisfy tax withholding obligations related to the vesting of restricted stock units awarded on December 6, 2024.
• Kamke's direct beneficial ownership of common stock after these transactions is 3,643 shares.
• On December 4, 2025, Kamke acquired various amounts of dividend equivalent rights (DERs) totaling 9.7448 shares, which accrued on restricted stock unit and performance share unit awards granted between December 11, 2021, and December 8, 2023.
• On December 6, 2025, 2 dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 6, 2024.
• The DERs are the economic equivalent of one share of the Issuer's common stock and vest proportionately with their underlying awards.

Sentiment

Score: 6

Explanation: The filing reflects routine executive compensation activities, including the vesting of equity awards and subsequent tax-related share dispositions. While there's a slight reduction in direct beneficial ownership due to tax withholding, the overall activity is neutral, indicating the normal course of executive compensation rather than a significant positive or negative event for the company's stock.

Positives

• Acquisition of 2 common shares at $0 price, indicating vesting of previously granted rights.
• Accrual of additional dividend equivalent rights (DERs) on existing restricted stock unit and performance share unit awards, increasing potential future share ownership.

Negatives

• Disposition of 69 shares to cover tax withholding obligations, reducing direct beneficial ownership by that amount.

Future Outlook

NA

Industry Context

This filing details routine insider transactions for an executive at a medical device company. Such transactions are common for executives receiving equity compensation and do not inherently reflect broader industry trends or competitive positioning.

Related Party Transactions

• The disposition of 69 shares was to the Issuer (Lemaitre Vascular Inc.) to satisfy tax withholding obligations, which is a common related-party transaction in executive compensation.

Stakeholder Impact

• Shareholders: The transactions are routine and reflect the compensation structure for executives. The slight reduction in direct beneficial ownership due to tax withholding is a common occurrence and not indicative of a change in management's confidence.
• Employees: The filing highlights the company's use of equity compensation (RSUs, PSUs, DERs) as part of its remuneration strategy for executives, which is a common practice across industries.

Key Dates

Recommendation

The Form 4 details routine insider transactions related to executive compensation, specifically the vesting of restricted stock units and dividend equivalent rights, and the subsequent sale of shares to cover tax obligations. These are expected events and do not provide new material information that would warrant a change in investment recommendation. The transactions reflect the normal course of business for executive equity awards at Lemaitre Vascular Inc. and do not indicate any significant shift in company fundamentals or management's confidence.

Keywords

Lemaitre Vascular, LMAT, Form 4, Insider Trading, Stock Transactions, Dividend Equivalent Rights, Restricted Stock Units, Performance Share Units, Executive Compensation, Trent G. Kamke